Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

14.87
Delayed Data
As of Dec 11
 -0.14 / -0.93%
Today’s Change
7.85
Today|||52-Week Range
22.67
-1.46%
Year-to-Date

Today’s Trading

Previous close15.01
Today’s open15.08
Day’s range14.78 - 15.30
Volume343,074
Average volume (3 months)766,927
Market cap$819.2M
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+7.56%
Earnings growth (this year)+15.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+261.96%
P/E ratioNM
Price/Sales1,973.06
Price/Book1.73

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc-0.30-3.75%
AKAOAchaogen Inc+0.21+1.89%
RETAReata Pharmaceutical...-2.11-8.31%
AKBAAkebia Therapeutics ...-0.31-1.96%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$330.7K
Annual profit (last year)-$116.4M
Net profit margin-35,205.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts